March 17, 2020 / 12:43 PM / 14 days ago

BRIEF-Singapore Edevelopment Says Studies Indicate Impact Biomedical's Linebacker & Equivir Performed Well In Inhibiting 3 Integral Mechanisms Of Sars-Cov-2

March 17 (Reuters) - Singapore eDevelopment Ltd:

* SINGAPORE EDEVELOPMENT-STUDIES INDICATE IMPACT BIOMEDICAL’S LINEBACKER & EQUIVIR PERFORMED WELL IN INHIBITING 3 INTEGRAL MECHANISMS OF SARS-COV-2

* SINGAPORE EDEVELOPMENT - EQUIVIR AND LINEBACKER ARE UNDERGOING ACCELERATED TESTING AGAINST SARS-COV-2 VIRUS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below